Retroviruses Rapid Tests & Point of Care (POC) - Medical Devices Pipeline Assessment, 2017

Published : Sep-2017

No. of Pages : 105

order by fax Inquire before Buying request discount

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 7
2 Introduction 8
2.1 Retroviruses Rapid Tests & Point of Care (POC) Overview 8
3 Products under Development 9
3.1 Retroviruses Rapid Tests & Point of Care (POC) - Pipeline Products by Stage of Development 9
3.2 Retroviruses Rapid Tests & Point of Care (POC) - Pipeline Products by Territory 10
3.3 Retroviruses Rapid Tests & Point of Care (POC) - Pipeline Products by Regulatory Path 11
3.4 Retroviruses Rapid Tests & Point of Care (POC) - Pipeline Products by Estimated Approval Date 12
4 Retroviruses Rapid Tests & Point of Care (POC) - Pipeline Products under Development by Companies 13
4.1 Retroviruses Rapid Tests & Point of Care (POC) Companies - Pipeline Products by Stage of Development 13
4.2 Retroviruses Rapid Tests & Point of Care (POC) - Pipeline Products by Stage of Development 15
5 Retroviruses Rapid Tests & Point of Care (POC) Companies and Product Overview 17
5.1 Akers Biosciences Inc Company Overview 17
5.1.1 Akers Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 17
5.2 Aldatu Biosciences, Inc. Company Overview 19
5.2.1 Aldatu Biosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 19
5.3 Atomo Diagnostics Pty Limited Company Overview 20
5.3.1 Atomo Diagnostics Pty Limited Pipeline Products & Ongoing Clinical Trials Overview 20
5.4 BBB Technologies Inc Company Overview 21
5.4.1 BBB Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 21
5.5 Bio-Alternative Medical Devices Ltd Company Overview 22
5.5.1 Bio-Alternative Medical Devices Ltd Pipeline Products & Ongoing Clinical Trials Overview 22
5.6 Biocartis SA Company Overview 23
5.6.1 Biocartis SA Pipeline Products & Ongoing Clinical Trials Overview 23
5.7 Biosynex SA Company Overview 24
5.7.1 Biosynex SA Pipeline Products & Ongoing Clinical Trials Overview 24
5.8 Calypte Biomedical Corporation Company Overview 25
5.8.1 Calypte Biomedical Corporation Pipeline Products & Ongoing Clinical Trials Overview 25
5.9 Centre International de Reference Chantal Biya Company Overview 27
5.9.1 Centre International de Reference Chantal Biya Pipeline Products & Ongoing Clinical Trials Overview 27
5.10 Cepheid Company Overview 28
5.10.1 Cepheid Pipeline Products & Ongoing Clinical Trials Overview 28
5.11 Chembio Diagnostic Systems Inc Company Overview 31
5.11.1 Chembio Diagnostic Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 31
5.12 Daktari Diagnostics, Inc. Company Overview 34
5.12.1 Daktari Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 34
5.13 Diagnostics For All Company Overview 36
5.13.1 Diagnostics For All Pipeline Products & Ongoing Clinical Trials Overview 36
5.14 Diagnostics for the Real World (Europe) Ltd. Company Overview 37
5.14.1 Diagnostics for the Real World (Europe) Ltd. Pipeline Products & Ongoing Clinical Trials Overview 37
5.15 Epinex Diagnostics Inc Company Overview 38
5.15.1 Epinex Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 38
5.16 ERBA Molecular Ltd Company Overview 39
5.16.1 ERBA Molecular Ltd Pipeline Products & Ongoing Clinical Trials Overview 39
5.17 GAIA Medical Institute LLC Company Overview 40
5.17.1 GAIA Medical Institute LLC Pipeline Products & Ongoing Clinical Trials Overview 40
5.18 genedrive plc Company Overview 41
5.18.1 genedrive plc Pipeline Products & Ongoing Clinical Trials Overview 41
5.19 Group K Diagnostics Company Overview 42
5.19.1 Group K Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 42
5.20 HeatFlow Technologies Inc Company Overview 43
5.20.1 HeatFlow Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 43
5.21 Jinvator Bio Med GmbH Company Overview 44
5.21.1 Jinvator Bio Med GmbH Pipeline Products & Ongoing Clinical Trials Overview 44
5.22 John Hopkins University Company Overview 45
5.22.1 John Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 45
5.23 Labsystems Diagnostics Oy Company Overview 46
5.23.1 Labsystems Diagnostics Oy Pipeline Products & Ongoing Clinical Trials Overview 46
5.24 Micronics Inc Company Overview 47
5.24.1 Micronics Inc Pipeline Products & Ongoing Clinical Trials Overview 47
5.25 Molbio Diagnostics Pvt. Ltd. Company Overview 49
5.25.1 Molbio Diagnostics Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 49
5.26 Northwestern Global Health Foundation Company Overview 50
5.26.1 Northwestern Global Health Foundation Pipeline Products & Ongoing Clinical Trials Overview 50
5.27 NOWDiagnostics Company Overview 51
5.27.1 NOWDiagnostics Pipeline Products & Ongoing Clinical Trials Overview 51
5.28 Omega Diagnostics Group Plc Company Overview 52
5.28.1 Omega Diagnostics Group Plc Pipeline Products & Ongoing Clinical Trials Overview 52
5.29 OPKO Health Inc Company Overview 53
5.29.1 OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview 53
5.30 OraSure Technologies Inc Company Overview 54
5.30.1 OraSure Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 54
5.31 Osel Inc Company Overview 55
5.31.1 Osel Inc Pipeline Products & Ongoing Clinical Trials Overview 55
5.32 QuantuMDx Group Ltd Company Overview 56
5.32.1 QuantuMDx Group Ltd Pipeline Products & Ongoing Clinical Trials Overview 56
5.33 Quidel Corp Company Overview 57
5.33.1 Quidel Corp Pipeline Products & Ongoing Clinical Trials Overview 57
5.34 Radisens Diagnostics Ltd Company Overview 60
5.34.1 Radisens Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 60
5.35 Rheonix Inc Company Overview 61
5.35.1 Rheonix Inc Pipeline Products & Ongoing Clinical Trials Overview 61
5.36 Roche Diagnostics International Ltd Company Overview 62
5.36.1 Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview 62
5.37 Sedia Biosciences Corp Company Overview 63
5.37.1 Sedia Biosciences Corp Pipeline Products & Ongoing Clinical Trials Overview 63
5.38 Trinity Biotech Plc Company Overview 65
5.38.1 Trinity Biotech Plc Pipeline Products & Ongoing Clinical Trials Overview 65
5.39 Wave 80 Biosciences Inc Company Overview 66
5.39.1 Wave 80 Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 66
6 Retroviruses Rapid Tests & Point of Care (POC)- Recent Developments 68
6.1 Jul 26, 2017: Quidel Reports Second Quarter 2017 Financial Results 68
6.2 Jul 24, 2017: OraQuick HIV Self-Test Selected for Next Phase of STAR Project for HIV Self-Testing in Africa 69
6.3 Jul 21, 2017: OraSure Technologies Receives World Health Organization Prequalification of OraQuick HIV Self-Test 70
6.4 Jul 20, 2017: Trinity Biotech Announces Results for Q2, 2017 71
6.5 Jul 18, 2017: Johnson & Johnson Reports 2017 Second-Quarter Results 72
6.6 Jun 27, 2017: OraSure Technologies to Drive Accelerated Adoption of OraQuick HIV Self-Test 74
6.7 May 17, 2017: VANC Pharmaceuticals Announces Canadian Distribution Agreement for INSTI HIV-1/HIV-2 Antibody Test 75
6.8 May 16, 2017: NOWDiagnostics CEO Kevin Clark to Address Technology Conference 76
6.9 May 03, 2017: Chembio Secures $5.8 Million Bio-Manguinhos Order to Supply Components for Production of DPP HIV 1/2 Assay in Brazil 76
6.10 Apr 27, 2017: Trinity Biotech Announces Results for Q1, 2017 77
6.11 Apr 24, 2017: Quidel Reports First Quarter 2017 Financial Results 78
6.12 Apr 19, 2017: Johnson & Johnson reports Q1 2017 results 79
6.13 Apr 18, 2017: Johnson & Johnson Reports 2017 First-Quarter Results 81
6.14 Mar 14, 2017: Trinity Biotech announces Quarter 4 and Fiscal Year 2016 Financial Results 83
6.15 Mar 01, 2017: OraSure Receives Global Fund Classification to Enable HIV Self-Test Procurement 86
6.16 Feb 21, 2017: BioLytical Receives Innovative Technology Contract from Vizient for Rapid HIV Test 86
6.17 Feb 08, 2017: Quidel Reports Fourth Quarter and Full Year 2016 Financial Results 87
6.18 Jan 24, 2017: Johnson & Johnson Reports 2016 Fourth-Quarter Results 88
6.19 Jan 23, 2017: Quidel Announces Modification of Revenue Reporting Categories 90
6.20 Jan 09, 2017: Johnson & Johnson Medical Devices Companies Launch CareAdvantage, a Suite of Holistic, Insights-Driven Capabilities to Help U.S. Health Systems Navigate Value-Based Care 91
6.21 Jan 06, 2017: Quidel Announces Preliminary Revenue for Fourth Quarter 2016 92
6.22 Dec 01, 2016: Daktari Awarded $1.3 Million NIH SBIR Grant for HIV Point-of-Care Diagnostic 92
6.23 Oct 26, 2016: Quidel Reports Third Quarter 2016 Financial Results 93
6.24 Oct 25, 2016: Trinity Biotech announces Quarter 3 Financial Results 94
6.25 Oct 25, 2016: Researchers Use CRISPR to Accelerate Search for HIV Cure 97
6.26 Oct 18, 2016: Johnson & Johnson Reports 2016 Third-Quarter Results 98
6.27 Sep 08, 2016: Cepheid Targets Development of a Point of Care HIV Viral Load Test From a Few Drops of Blood 100
7 Appendix 102
7.1 Methodology 102
7.2 About GlobalData 105
7.3 Contact Us 105
7.4 Disclaimer 105

1.1 List of Tables
Table 1: Retroviruses Rapid Tests & Point of Care (POC) - Pipeline Products by Stage of Development 9
Table 2: Retroviruses Rapid Tests & Point of Care (POC) - Pipeline Products by Territory 10
Table 3: Retroviruses Rapid Tests & Point of Care (POC) - Pipeline Products by Regulatory Path 11
Table 4: Retroviruses Rapid Tests & Point of Care (POC) - Pipeline Products by Estimated Approval Date 12
Table 5: Retroviruses Rapid Tests & Point of Care (POC) Companies - Pipeline Products by Stage of Development 13
Table 6: Retroviruses Rapid Tests & Point of Care (POC) - Pipeline Products by Stage of Development 15
Table 7: Akers Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 17
Table 8: PIFA HIV 1+2 Rapid Assay - Product Status 17
Table 9: PIFA HIV 1+2 Rapid Assay - Product Description 18
Table 10: Aldatu Biosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 19
Table 11: PANDAA HIV6 - Product Status 19
Table 12: PANDAA HIV6 - Product Description 19
Table 13: Atomo Diagnostics Pty Limited Pipeline Products & Ongoing Clinical Trials Overview 20
Table 14: AtomoRapid HIV - Product Status 20
Table 15: AtomoRapid HIV - Product Description 20
Table 16: BBB Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 21
Table 17: Mobile RDT Reader - HIV1/2 Test - Product Status 21
Table 18: Mobile RDT Reader - HIV1/2 Test - Product Description 21
Table 19: Bio-Alternative Medical Devices Ltd Pipeline Products & Ongoing Clinical Trials Overview 22
Table 20: Digital Strip Reader - HIV - Product Status 22
Table 21: Digital Strip Reader - HIV - Product Description 22
Table 22: Biocartis SA Pipeline Products & Ongoing Clinical Trials Overview 23
Table 23: Idylla Viral Load Assay - HIV - Product Status 23
Table 24: Idylla Viral Load Assay - HIV - Product Description 23
Table 25: Biosynex SA Pipeline Products & Ongoing Clinical Trials Overview 24
Table 26: Exacto HIV Screening Test - Product Status 24
Table 27: Exacto HIV Screening Test - Product Description 24
Table 28: Calypte Biomedical Corporation Pipeline Products & Ongoing Clinical Trials Overview 25
Table 29: Aware 2 HIV-1/2 - Product Status 25
Table 30: Aware 2 HIV-1/2 - Product Description 25
Table 31: Aware HIV-1/2 OMT - Product Status 26
Table 32: Aware HIV-1/2 OMT - Product Description 26
Table 33: Centre International de Reference Chantal Biya Pipeline Products & Ongoing Clinical Trials Overview 27
Table 34: Point-Of-Care Diagnostic Test - HIV-1 - Product Status 27
Table 35: Point-Of-Care Diagnostic Test - HIV-1 - Product Description 27
Table 36: Cepheid Pipeline Products & Ongoing Clinical Trials Overview 28
Table 37: GeneXpert Omni - Xpert HIV-1 Qualitative - Product Status 28
Table 38: GeneXpert Omni - Xpert HIV-1 Qualitative - Product Description 28
Table 39: GeneXpert Omni - Xpert HIV-1 Viral Load - Product Status 29
Table 40: GeneXpert Omni - Xpert HIV-1 Viral Load - Product Description 29
Table 41: Xpert Finger Stick HIV-1 Viral Load Assay - Product Status 29
Table 42: Xpert Finger Stick HIV-1 Viral Load Assay - Product Description 30
Table 43: Chembio Diagnostic Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 31
Table 44: DPP HIV Ag-Ab Assay - Product Status 31
Table 45: DPP HIV Ag-Ab Assay - Product Description 31
Table 46: Next Generation DPP HIV ½ Oral Fluid Assay - Product Status 32
Table 47: Next Generation DPP HIV ½ Oral Fluid Assay - Product Description 32
Table 48: Sure Check HIV OTC Assay - Product Status 32
Table 49: Sure Check HIV OTC Assay - Product Description 33
Table 50: Daktari Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 34
Table 51: Aspect - HIV Viral Load Test - Product Status 34
Table 52: Aspect - HIV Viral Load Test - Product Description 34
Table 53: HIV Viral Load Test - Product Status 35
Table 54: HIV Viral Load Test - Product Description 35
Table 55: Diagnostics For All Pipeline Products & Ongoing Clinical Trials Overview 36
Table 56: Paper-Based Microfluidic Device - HIV - Product Status 36
Table 57: Paper-Based Microfluidic Device - HIV - Product Description 36
Table 58: Diagnostics for the Real World (Europe) Ltd. Pipeline Products & Ongoing Clinical Trials Overview 37
Table 59: SAMBA - HIV-1 Viral Load Assay - Product Status 37
Table 60: SAMBA - HIV-1 Viral Load Assay - Product Description 37
Table 61: Epinex Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 38
Table 62: Epinex G1A - Neo-natal HIV Test - Product Status 38
Table 63: Epinex G1A - Neo-natal HIV Test - Product Description 38
Table 64: ERBA Molecular Ltd Pipeline Products & Ongoing Clinical Trials Overview 39
Table 65: Next Generation HIV Viral Load Monitoring Test - Product Status 39
Table 66: Next Generation HIV Viral Load Monitoring Test - Product Description 39
Table 67: GAIA Medical Institute LLC Pipeline Products & Ongoing Clinical Trials Overview 40
Table 68: Point-Of-Care Diagnostic Test - HIV - Product Status 40
Table 69: Point-Of-Care Diagnostic Test - HIV - Product Description 40
Table 70: genedrive plc Pipeline Products & Ongoing Clinical Trials Overview 41
Table 71: Genedrive - HIV Assay - Product Status 41
Table 72: Genedrive - HIV Assay - Product Description 41
Table 73: Group K Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 42
Table 74: Multidiagnostic - HIV Load Test - Product Status 42
Table 75: Multidiagnostic - HIV Load Test - Product Description 42
Table 76: HeatFlow Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 43
Table 77: HF-PCR Point Of Care HIV Viral Load Assay - Product Status 43
Table 78: HF-PCR Point Of Care HIV Viral Load Assay - Product Description 43
Table 79: Jinvator Bio Med GmbH Pipeline Products & Ongoing Clinical Trials Overview 44
Table 80: nanoGold Test - Product Status 44
Table 81: nanoGold Test - Product Description 44
Table 82: John Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 45
Table 83: Point-Of-Care Test - Pediatric HIV - Product Status 45
Table 84: Point-Of-Care Test - Pediatric HIV - Product Description 45
Table 85: Labsystems Diagnostics Oy Pipeline Products & Ongoing Clinical Trials Overview 46
Table 86: Biocard HIV (1+2) Test - Product Status 46
Table 87: Biocard HIV (1+2) Test - Product Description 46
Table 88: Micronics Inc Pipeline Products & Ongoing Clinical Trials Overview 47
Table 89: MTCT - HIV Assay - Product Status 47
Table 90: MTCT - HIV Assay - Product Description 47
Table 91: PanNAT - HIV Assay - Product Status 48
Table 92: PanNAT - HIV Assay - Product Description 48
Table 93: Molbio Diagnostics Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 49
Table 94: Truenat HIV Viral Load Assay - Product Status 49
Table 95: Truenat HIV Viral Load Assay - Product Description 49
Table 96: Northwestern Global Health Foundation Pipeline Products & Ongoing Clinical Trials Overview 50
Table 97: LYNX HIV p24 Antigen Test - Product Status 50
Table 98: LYNX HIV p24 Antigen Test - Product Description 50
Table 99: NOWDiagnostics Pipeline Products & Ongoing Clinical Trials Overview 51
Table 100: ADEXUSDx HIV Test - Product Status 51
Table 101: ADEXUSDx HIV Test - Product Description 51
Table 102: Omega Diagnostics Group Plc Pipeline Products & Ongoing Clinical Trials Overview 52
Table 103: VISITECT CD4 Test - Product Status 52
Table 104: VISITECT CD4 Test - Product Description 52
Table 105: OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview 53
Table 106: Diagnostic Assay - HIV - Product Status 53
Table 107: Diagnostic Assay - HIV - Product Description 53
Table 108: OraSure Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 54
Table 109: Next Generation OraQuick Rapid HIV Test - Product Status 54
Table 110: Next Generation OraQuick Rapid HIV Test - Product Description 54
Table 111: Osel Inc Pipeline Products & Ongoing Clinical Trials Overview 55
Table 112: Point-Of-Care Diagnostic Test - HIV-1 Infection - Product Status 55
Table 113: Point-Of-Care Diagnostic Test - HIV-1 Infection - Product Description 55
Table 114: QuantuMDx Group Ltd Pipeline Products & Ongoing Clinical Trials Overview 56
Table 115: Q-POC - HIV Assay - Product Status 56
Table 116: Q-POC - HIV Assay - Product Description 56
Table 117: Quidel Corp Pipeline Products & Ongoing Clinical Trials Overview 57
Table 118: HIV POC RT-PCR Testing Device - Product Status 57
Table 119: HIV POC RT-PCR Testing Device - Product Description 57
Table 120: IsoAmp Assay - HIV - Product Status 58
Table 121: IsoAmp Assay - HIV - Product Description 58
Table 122: IsoAmp HIV-1 Quantitative Assay - Product Status 58
Table 123: IsoAmp HIV-1 Quantitative Assay - Product Description 59
Table 124: Radisens Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 60
Table 125: Diagnostic Panel - HIV - Product Status 60
Table 126: Diagnostic Panel - HIV - Product Description 60
Table 127: Rheonix Inc Pipeline Products & Ongoing Clinical Trials Overview 61
Table 128: Rheonix CARD - HIV Assay - Product Status 61
Table 129: Rheonix CARD - HIV Assay - Product Description 61
Table 130: Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview 62
Table 131: Liat HIV-1 Viral Load Assay - Product Status 62
Table 132: Liat HIV-1 Viral Load Assay - Product Description 62
Table 133: Sedia Biosciences Corp Pipeline Products & Ongoing Clinical Trials Overview 63
Table 134: Asanté Rapid HIV-1 Recency (or Incidence) Assay - Product Status 63
Table 135: Asanté Rapid HIV-1 Recency (or Incidence) Assay - Product Description 63
Table 136: Rapid Oral Fluid HIV Test - Product Status 64
Table 137: Rapid Oral Fluid HIV Test - Product Description 64
Table 138: Trinity Biotech Plc Pipeline Products & Ongoing Clinical Trials Overview 65
Table 139: Uni-Gold HIV Ag/Ab Combo Test - Product Status 65
Table 140: Uni-Gold HIV Ag/Ab Combo Test - Product Description 65
Table 141: Wave 80 Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 66
Table 142: EOSCAPE HIV-1 RNA Viral Load Test - Product Status 66
Table 143: EOSCAPE HIV-1 RNA Viral Load Test - Product Description 66
Table 144: EOSCAPE-HIV RNA PLUS - Product Status 67
Table 145: EOSCAPE-HIV RNA PLUS - Product Description 67
Table 146: Glossary 104

1.2 List of Figures
Figure 1: Retroviruses Rapid Tests & Point of Care (POC) - Pipeline Products by Stage of Development 9
Figure 2: Retroviruses Rapid Tests & Point of Care (POC) - Pipeline Products by Territory 10
Figure 3: Retroviruses Rapid Tests & Point of Care (POC) - Pipeline Products by Regulatory Path 11
Figure 4: Retroviruses Rapid Tests & Point of Care (POC) - Pipeline Products by Estimated Approval Date 12

Filed in: Medical Device

Publisher : GlobalData

Name:
Email:
Phone:
Subject:
Comments:

More Reports

Title	Price	Buy Now
Wound Care Market by Product (Dressings (Foam, Film, Hydrocolloid, Collagen), Devices (NPWT, Assessment, Debridement), Graft, Matrix, Suture, Stapler), Wound(DFUs, Trauma, Surgical, Burn), End User (Hospitals, Clinics) & Region – Global Forecast to 2027 “Increased cases of traumatic injuries and increasing surgical procedures worldwide are driving the overall growth of the wound care market” The global wound care market is projected to reach USD 27.2 billion by 2027 from USD 20.8 billion in 2022, at a CAGR of 5.4% during the forecast period. Market growth is driven by factors such as increase in traumatic injuries, increased in number of surgical wounds and increased spending on traumatic wound management. On the other hand, challenges associated with wound care product validation and shortage of skilled professionals are the major factors hampering the growth of this market. “The advanced wound care products segment accounted for the highest growth rate in the wound care market, by product, during the forecast period” T......	$8150
Rehabilitation Equipment Market by Product (Medical Bed, Mobility Scooter, Walker, Crutcher, Cane, Patient Lift, Sling), Application (Physical, OT, Lower-body Exercise Equipment), End User (Rehabilitation & Physiotherapy Center) – Global Forecast to 2027 “The rehabilitation equipment market is projected to grow at a CAGR of 5.9% between 2022 and 2027.” The global rehabilitation equipment market is projected to reach USD 19.8 billion by 2027 from USD 14.9 billion in 2022, at a CAGR of 5.9% during the forecast period. Increasing geriatric population and obese populations, increasing chronic diseases, high risk of injuries to caregivers during the manual handling of patients, and increasing demand for rehabilitation care, owing to an increasing access to healthcare are the key driving factors in the market. However, a lack of awareness and access to rehabilitation services in emerging countries is a major factor restraining market growth. “Therapy equipment was the largest and fastest-growing segment in the product segment of reha......	$4950
Cold Pain Therapy Market by Product (OTC (Gels, Creams, Patches, Wraps, Pads), Prescription (Motorized, Non-motorized)), Application (Musculoskeletal, Post-Op, Sports Injuries), Distribution Channel (Hospital, Retail, E-Pharmacy) – Global Forecast to 2027 "Increasing sports injuries and active participation are driving the overall growth of the cold pain therapy market." The global cold pain therapy market is projected to reach USD 2.4 billion by 2027 from USD 1.8 billion in 2022, at a CAGR of 5.1% during the forecast period. Growth in this market is mainly driven by growing incidence of arthritis and availability of cold pain products at affordable cost. "The OTC products segment accounted for the highest growth rate in the cold pain therapy market, by product, during the forecast period." The cold pain therapy market is segmented into OTC products and prescription products based on product. In 2021, the OTC products segment accounted for the highest growth rate in the cold pain therapy market. Market growth can largely be attri......	$4950
Nerve Repair & Regeneration Market by Products (Neuromodulation Devices (Deep Brain Stimulation, Vagus Nerve Stimulation), Biomaterials (Nerve Conduits, Nerve Wraps), Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy) – Global Forecast to 2027 “Increasing research investments into the neurological compilations and the expanding geriatric population are pushing the growth of the nerve repair & regeneration market.” The global nerve repair & regeneration market is expected to reach USD 11.6 billion by 2027 from USD 6.5 billion in 2022, at a CAGR of 12.1%.The growth in this market is driven by increasing research expenditure on the neurological disorders by the government, the increasing R&D investments by the market players into the neuromodulation and neurostimulation devices and the biomaterials. Also, the expanding geriatric population base dries the growth of the market by placing more demand of the nerve repair and regeneration products. “The biomaterialas segment is anticipated to grow at the fastest ......	$4950
Particle Therapy Market by Type (Proton Therapy, Heavy Ion), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate), Application (Treatment, Research) – Global Forecast to 2027 MarketsandMarkets expects particle therapy market is projected to reach USD 1,004 million by 2027 from USD 677 million in 2022, growing at a CAGR of 8.2% from 2022 to 2027. Market growth is driven by factors such as the various advantages offered by the growing global prevalence of cancer, particle therapy advantages over photon therapy, increasing acceptance of particle therapy in clinical trials, and the increasing number of particle therapy centers worldwide. However, affordability & accessibility of treatments and infrastructural are expected to limit market growth to a certain extent in the coming years. In this report, the particle therapy market is segmented on the basis of type, product and services, cancer type, application, cancer type, and region. “Treatment Applicat......	$4950
Restorative Dentistry Market by Product (Restorative Material (Glass-ionomers, Bonding Agents, Biomaterial), Implant, Prosthetic, Equipment (Handpiece, Articulator, Furnace), End User (Hospital, Clinic, Laboratory) – Global Forecast to 2027 “The global restorative dentistry market is projected to grow at a CAGR of 6.1%” Restorative dentistry restores mouth functions & its aesthetic state by efficiently managing oral health problems through dental restoration. Dental restoration procedures include the use of implants and prosthetics made by restorative material to restore the function, integrity, and morphology of the missing tooth or to repair the missing parts of the tooth structure resulted from dental caries or injuries. The global restorative dentistry market is projected to reach USD 22.2 billion by 2027 from USD 16.5 billion in 2022, at a CAGR of 6.1%. “The prosthetic materials segment is expected to account for the largest share of the restorative dentistry market” The prosthetic materials segment ......	$4950
Dental Laboratories Market by Material (Metal Ceramic, CAD/CAM Material (Zirconia, Glass Ceramic)), Equipment (Milling Equipment, CAD/CAM System, 3D Printing System, Scanner, Furnace), Prosthetics (Bridge, Crown, Veeners, Denture) – Global Forecast to 2027 “Rapid growth in the geriatric population and the associated increase in the prevalence of edentulism is expected to drive the overall growth of the dental laboratories market.” Edentulism (tooth loss) is a major oral health concern among the elderly; according to the WHO (2020), globally, ~19% of individuals aged between 65 and 74 years are edentulous. Periodontal diseases and dental cavities are the major causes of tooth loss. As the elderly are more susceptible to such ailments, the growth of this population segment will increase the number of people suffering from oral health problems globally. According to the UN, the global geriatric population (aged 65 years and above) will increase from 703 million in 2019 to 1.5 billion in 2050. Thus, significant growth in the geriatric pop......	$4950
Endoscope Reprocessing Market by Product (HLD and Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors (AER), Endoscope Drying, Storage, & Transport Systems, Tracking Solutions), End User (Hospitals, ASCs & Clinics) (2022 – 2027) “Endoscope reprocessing market is projected to grow at CAGR of 9.7% from 2022 to 2027” The global endoscope reprocessing market is projected to USD 3.8 billion by 2027 from USD 2.4 billion in 2022, at a CAGR of 9.7% from 2022 to 2027.The growth of this market is driven owing to increasing requirement for endoscopy to diagnose and treat target diseases, high risk of Endoscope-associated infections due to contaminated endoscopes, Growing geriatric population and leading to increase in endoscopic procedures, and Increasing emphasis on improving reprocessing guidelines by healthcare authorities. Also, Increasing investments, funds, and grants to improve healthcare infrastructure and research areas of endoscopy is anticipated to offer an opportunity for the growth of the market during th......	$4950
Polymethyl Methacrylate (PMMA) Market by Grade (General Purpose, Optical), Form(Extruded Sheet, Cast Acrylic Sheet, Pellets, Beads),End-Use Industry(Signs & Displays, Construction, Automotive, Lighting Fixtures, Electronics, Marine, Healthcare) & Region – Global Forecast to 2027 “Rising demand from the electronics industry and expected recovery from impact of COVID-19 and rising penetration of EVs expected to drive market.” The global Polymethyl Methacrylate (PMMA) market is projected to grow from USD 4.8 Billion in 2022 to USD 6.3 Billion by 2027, at a CAGR of 5.4% during the forecast period. Increasing usage of PMMA in construction, automotive, electronics, and other end-use industries are driving the demand for PMMA during the forecast period. However, availability of low-cost substitutes is expected to hamper market growth. PMMA is a versatile, recyclable, sustainable, and durable material, owing to which it is gaining traction across several industrial applications. Due to its superior properties and the changing government policies such as European Gr......	$4950
Microtome Market by Product (Instruments, (Rotary), Accessories (Microtome Blades), Application (Disease Diagnosis, Medical Research), Technology (Fully Automated, Semi-automated, Manual), End User (Hospital, Clinical Labs) – Global Forecast to 2027 “The hospital laboratories is projected to grow at CAGR of 7.1% from 2022 to 2027” Based on End user the market is classified into, The hospital laboratories, clinical laboratories, and other end users . The growth of this market is majorly driven by the increasing number of specialty diagnostic tests performed in hospital laboratories, rising number of in-house clinical diagnostic procedures in hospitals, rising number of hospitals across the globe, and the growing trend of establishing in-house clinical diagnostic capabilities in hospitals. “Microtome instruments in the product segment to witness the highest shares during the forecast period.” Based on the product, the microtome market is segmented into Microtome Instruments: Rotary Microtomes, Cryostat Microtomes, Vibra......	$4950

Retroviruses Rapid Tests & Point of Care (POC) - Medical Devices Pipeline Assessment, 2017

Benefits of Sandler Research

User License for Reports

Reach Us

Contact Us

Knowledge Store

Email Subscription

our Feed Reader

Wound Care Market by Product (Dressings (Foam, Film, Hydrocolloid, Collagen), Devices (NPWT, Assessment, Debridement), Graft, Matrix, Suture, Stapler), Wound(DFUs, Trauma, Surgical, Burn), End User (Hospitals, Clinics) & Region – Global Forecast to 2027

Rehabilitation Equipment Market by Product (Medical Bed, Mobility Scooter, Walker, Crutcher, Cane, Patient Lift, Sling), Application (Physical, OT, Lower-body Exercise Equipment), End User (Rehabilitation & Physiotherapy Center) – Global Forecast to 2027

Cold Pain Therapy Market by Product (OTC (Gels, Creams, Patches, Wraps, Pads), Prescription (Motorized, Non-motorized)), Application (Musculoskeletal, Post-Op, Sports Injuries), Distribution Channel (Hospital, Retail, E-Pharmacy) – Global Forecast to 2027

Nerve Repair & Regeneration Market by Products (Neuromodulation Devices (Deep Brain Stimulation, Vagus Nerve Stimulation), Biomaterials (Nerve Conduits, Nerve Wraps), Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy) – Global Forecast to 2027

Particle Therapy Market by Type (Proton Therapy, Heavy Ion), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate), Application (Treatment, Research) – Global Forecast to 2027

Restorative Dentistry Market by Product (Restorative Material (Glass-ionomers, Bonding Agents, Biomaterial), Implant, Prosthetic, Equipment (Handpiece, Articulator, Furnace), End User (Hospital, Clinic, Laboratory) – Global Forecast to 2027

Dental Laboratories Market by Material (Metal Ceramic, CAD/CAM Material (Zirconia, Glass Ceramic)), Equipment (Milling Equipment, CAD/CAM System, 3D Printing System, Scanner, Furnace), Prosthetics (Bridge, Crown, Veeners, Denture) – Global Forecast to 2027

Endoscope Reprocessing Market by Product (HLD and Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors (AER), Endoscope Drying, Storage, & Transport Systems, Tracking Solutions), End User (Hospitals, ASCs & Clinics) (2022 – 2027)

Polymethyl Methacrylate (PMMA) Market by Grade (General Purpose, Optical), Form(Extruded Sheet, Cast Acrylic Sheet, Pellets, Beads),End-Use Industry(Signs & Displays, Construction, Automotive, Lighting Fixtures, Electronics, Marine, Healthcare) & Region – Global Forecast to 2027

Microtome Market by Product (Instruments, (Rotary), Accessories (Microtome Blades), Application (Disease Diagnosis, Medical Research), Technology (Fully Automated, Semi-automated, Manual), End User (Hospital, Clinical Labs) – Global Forecast to 2027